Fenoldopam mesylate Size:Solid 2 mg inhibits oxidative phosphorylation and all

inhibits oxidative phosphorylation and all the ATP-dependent processes occurring on the coupling membrane of mitochondria

2-3H3/t16-

Cardiac arrhythmias are ameliorated by local inhibition of angiotensin formation and bradykinin degradation with the converting-enzyme inhibitor ramipril

Clofarabine is phosphorylated intracellularly to the cytotoxic active 5'-triphosphate metabolite

Fenoldopam mesylate Size:Solid 2 mg inhibits oxidative phosphorylation and allFenoldopam mesylate is a synthetic benzazepine derivative which acts as a selective D1 receptor partial agonist. Fenoldopam is used as an antihypertensive agent. It was approved by the Food and Drug Administration (FDA) in September 1997. Since fenoldopam is the only intravenous agent that improves renal perfusion, in theory it could be beneficial in hypertensive patients with concomitant renal insufficiency. Product information CAS Number: 67227 57 0